Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Does elevated TMAO increase arterial thrombotic risk?

Elevated circulating TMAO promotes vascular inflammation and platelet hyperreactivity, increasing arterial thrombotic susceptibility.

PlausibleJuly 1, 202618 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Higher trimethylamine N-oxide (TMAO) is linked to pro-atherogenic signaling and increased platelet reactivity, which can increase thrombotic susceptibility in humans.

laying out figure…
2 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim links higher TMAO to pro-atherogenic vascular signaling that impairs endothelial function via inflammatory cascades, and to a procoagulant shift through increased endothelial Tissue Factor. It also describes direct augmentation of platelet intracellular Ca2+ signaling that lowers the threshold for activation, together driving greater thrombotic risk.

Verified conclusion

Trimethylamine N-oxide (TMAO), a gut microbiota-derived metabolite, acts as a key mediator linking gut microbial metabolism to cardiovascular disease by promoting vascular pathology and hypercoagulability.

Pro-atherogenic signaling

  • Inflammatory pathway activation: TMAO promotes vascular inflammation and plaque formation by activating canonical inflammatory cascades, specifically the MAPK/ERK, JNK, and NF-κB pathways, alongside the ROS-TXNIP-NLRP3 inflammasome axis.
  • Endothelial dysfunction: This inflammatory signaling impairs nitric oxide bioavailability and upregulates endothelial adhesion molecules, establishing a highly pro-atherogenic vascular environment.

Platelet hyperreactivity and thrombotic mechanisms

  • Intracellular calcium signaling: TMAO enhances platelet response to submaximal agonist concentrations (such as ADP, thrombin, and collagen) by altering inositol 1,4,5-trisphosphate (IP3) signaling. This amplifies intracellular calcium ($Ca^{2+}$) mobilization from the dense tubular system, driving dense-granule secretion, integrin activation, and platelet hyperreactivity.
  • Extrinsic coagulation pathway: TMAO exposure causes a procoagulant shift by increasing the expression and activity of endothelial Tissue Factor, which directly drives the extrinsic coagulation cascade.
  • Clinical implications: Dietary choline supplementation trials show that raising TMAO levels directly induces a dose-dependent increase in ADP-evoked platelet aggregation. Furthermore, prospective cohort data confirm that elevated plasma TMAO levels independently predict a heightened 3-year incident risk of major adverse cardiovascular events, including myocardial infarction and stroke.

Bottom line

  • Key takeaway: Elevated circulating TMAO significantly increases arterial thrombotic susceptibility through a dual mechanism: promoting pro-inflammatory, tissue-factor-mediated vascular signaling and directly lowering the threshold for platelet activation via augmented intracellular calcium mobilization.

References

  1. Trimethylamine N-oxide induces inflammation and endothelial ... — sciencedirect.com ↗
  2. Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation ... — pubmed.ncbi.nlm.nih.gov ↗
  3. Gut Microbiota-Dependent Marker TMAO in Promoting ... - Frontiers — frontiersin.org ↗
  4. Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway — pmc.ncbi.nlm.nih.gov ↗
  5. [PDF] The roles of trimethylamine-N-oxide in atherosclerosis and its ... — pdfs.semanticscholar.org ↗
  6. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk — pmc.ncbi.nlm.nih.gov ↗
  7. The roles of trimethylamine-N-oxide in atherosclerosis and its ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  8. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity ... — pubmed.ncbi.nlm.nih.gov ↗
  9. [PDF] Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity ... — engagedscholarship.csuohio.edu ↗
  10. Choline, Common in Eggs and Liver, Raises TMAO Levels and ... — tctmd.com ↗
  11. The gut microbial metabolite trimethylamine N-oxide and ... - Frontiers — frontiersin.org ↗
  12. Flavin monooxygenase 3, the host hepatic enzyme in the ... — onlinelibrary.wiley.com ↗
  13. Development of a gut microbe–targeted nonlethal therapeutic to ... — escholarship.org ↗
  14. TMAO: a potential mediator of clopidogrel resistance - Nature — nature.com ↗
  15. Gut Microbiota-Derived Metabolites and Cardiovascular Disease — pubs.acs.org ↗
  16. Vascular endothelial Tissue Factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis. — pmc.ncbi.nlm.nih.gov ↗
  17. Trimethylamine N-oxide in cardiovascular disease — advances.umw.edu.pl ↗
  18. TMAO metaorganismal pathway and chronic inflammatory diseases — explorationpub.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→